| Pioneer Medical Group Inc. | |
|
10251 Artesia Blvd Bellflower CA 90706-6719 | |
| (562) 229-9452 | |
| (562) 920-4642 |
| Full Name | Pioneer Medical Group Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 10251 Artesia Blvd, Bellflower, California |
| Authorized Official Name and Position | William G Wong (PRESIDENT) |
| Authorized Official Contact | 5622299452 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pioneer Medical Group Inc. Po Box 1682 Bellflower CA 90707-1682 Ph: (562) 229-9452 | Pioneer Medical Group Inc. 10251 Artesia Blvd Bellflower CA 90706-6719 Ph: (562) 229-9452 |
| NPI Number | 1548303589 |
|---|---|
| Provider Enumeration Date | 02/15/2007 |
| Last Update Date | 11/01/2010 |
| Medicare PECOS PAC ID | 1759317696 |
|---|---|
| Medicare Enrollment ID | O20050712001246 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548303589 | NPI | - | NPPES |
| CJ3784 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Saeed Yadegar |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1912015652 PECOS PAC ID: 6103729181 Enrollment ID: I20040128000569 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Madhuri Petkar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962428144 PECOS PAC ID: 7315932951 Enrollment ID: I20040414001972 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | James C Lee |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1437253663 PECOS PAC ID: 1850387697 Enrollment ID: I20040426000417 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Angelyn M Moultrie-lizana |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295749547 PECOS PAC ID: 6608804539 Enrollment ID: I20050801000872 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Vinod D Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1043226756 PECOS PAC ID: 4284655853 Enrollment ID: I20051209000769 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Thilan P Fernando |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316146632 PECOS PAC ID: 2062570781 Enrollment ID: I20081024000451 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Paul S Yoon |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174610125 PECOS PAC ID: 8527129188 Enrollment ID: I20081202000317 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Dennis H Watanabe |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851404040 PECOS PAC ID: 3476608019 Enrollment ID: I20090902000509 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Randall K Harada |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1316972334 PECOS PAC ID: 3577696079 Enrollment ID: I20100804000898 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Jada Mandy Ma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568440618 PECOS PAC ID: 1153516638 Enrollment ID: I20101110000198 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Jorge Echeverri |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376556506 PECOS PAC ID: 6800076266 Enrollment ID: I20110202000690 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Sanatkumar D Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336155597 PECOS PAC ID: 1951581321 Enrollment ID: I20110202000740 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Arthur Pazornik |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1922019389 PECOS PAC ID: 8325228562 Enrollment ID: I20110204000964 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Joel G Golden |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386651230 PECOS PAC ID: 7214845015 Enrollment ID: I20110204000969 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Jerry F Floro |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1801802079 PECOS PAC ID: 3375579212 Enrollment ID: I20110209000072 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Charles K Kung |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1922014174 PECOS PAC ID: 5698955367 Enrollment ID: I20110212000090 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Marc R Baskin |
|---|---|
| Provider Type | Practitioner - Allergy/immunology |
| Provider Identifiers | NPI Number: 1124035076 PECOS PAC ID: 0941481030 Enrollment ID: I20110223000072 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Ernesto K Cortez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164436408 PECOS PAC ID: 5092996199 Enrollment ID: I20110223000138 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Emerico P Csepanyi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659395036 PECOS PAC ID: 3476734583 Enrollment ID: I20110223000206 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Augusto W Rodriguez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013924802 PECOS PAC ID: 7214118330 Enrollment ID: I20110223000295 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Michael S Maehara |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316969629 PECOS PAC ID: 2567643497 Enrollment ID: I20110224000496 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Pinal Doshi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326062712 PECOS PAC ID: 5991987695 Enrollment ID: I20110316000307 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Laura K Sullivan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700892437 PECOS PAC ID: 7911183801 Enrollment ID: I20110510000549 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Dionisio Dabu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1538272885 PECOS PAC ID: 8325224223 Enrollment ID: I20110510000601 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Edwardo C Tellez |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1104833516 PECOS PAC ID: 8123292349 Enrollment ID: I20111123000632 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Manuel Chon |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1568478725 PECOS PAC ID: 5395919526 Enrollment ID: I20111128000026 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Jung-mok M Park |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1508872243 PECOS PAC ID: 7911172044 Enrollment ID: I20111219000395 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Rebecca Knight |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053327270 PECOS PAC ID: 2062688740 Enrollment ID: I20111229000779 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Stephen Kato |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1144236399 PECOS PAC ID: 9931375441 Enrollment ID: I20120105000250 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Kerry L Sheu |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1174636310 PECOS PAC ID: 5991971350 Enrollment ID: I20120105000986 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Joseph A Lombardo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1093726457 PECOS PAC ID: 3274700992 Enrollment ID: I20120120000787 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Todd Stockwell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1336150705 PECOS PAC ID: 8123295474 Enrollment ID: I20120127000098 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Arshia Hashmy |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1528073269 PECOS PAC ID: 9638346984 Enrollment ID: I20120127000133 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | David C Blakely |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1649303462 PECOS PAC ID: 9739356098 Enrollment ID: I20120127000240 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Kathleen L Morgan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245363969 PECOS PAC ID: 8426153594 Enrollment ID: I20121109000537 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Vimala T Reddy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801821855 PECOS PAC ID: 8123279395 Enrollment ID: I20121116000098 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Stela Georgieva Kostova-abadjieva |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164791265 PECOS PAC ID: 9739331588 Enrollment ID: I20121130000561 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Richard Jordan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639212558 PECOS PAC ID: 1456592187 Enrollment ID: I20130723000701 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Johana Flores Rios |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1265708531 PECOS PAC ID: 6901033661 Enrollment ID: I20131230001321 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Sasha Maher |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1467630640 PECOS PAC ID: 1153548250 Enrollment ID: I20140813002954 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Maria N Mejia-perez |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1558706804 PECOS PAC ID: 7214156967 Enrollment ID: I20140912000010 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Pei L Mulroy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568892115 PECOS PAC ID: 4284855065 Enrollment ID: I20141020001554 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Jane B Kong |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1912910357 PECOS PAC ID: 4284632894 Enrollment ID: I20150522002071 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Patrick J Mulroy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619230810 PECOS PAC ID: 0446567903 Enrollment ID: I20150915003295 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Salima Hassanali |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326363565 PECOS PAC ID: 1557539475 Enrollment ID: I20161216001644 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Niraj Karki |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1952670309 PECOS PAC ID: 9537385976 Enrollment ID: I20170419000885 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Teresa J Kim |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386078327 PECOS PAC ID: 0648547109 Enrollment ID: I20170605001230 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Puja Shrestha |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376964718 PECOS PAC ID: 1456570126 Enrollment ID: I20171228001076 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
| Provider Name | Larisa Garbar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1811906753 PECOS PAC ID: 5193626158 Enrollment ID: I20191030001738 |
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
News Archive
National Imaging Associates (NIA), a Magellan Health Services company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue of radiation overexposure through its Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging.
Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question.
"Under the president's budget for FY 2014, more than nine million women—women who are young, poor or disabled, as well as women serving our country in the military, the Peace Corps, the civil service and many others—will be denied coverage for abortion," said Jon O'Brien, president of Catholics for Choice.
› Verified 8 days ago
Hope Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17814 Woodruff Avenue, Suite 1 And 2, Bellflower, CA 90706 Phone: 562-920-9777 Fax: 562-920-9730 | |
Universal Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17660 Lakewood Boulevard, Bellflower, CA 90706 Phone: 562-461-1179 Fax: 562-804-0862 | |
Wesley Health Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14371 Clark Ave, Bellflower, CA 90706 Phone: 562-867-6006 Fax: 562-867-6333 | |
Edgardo G Binoya Md A Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10230 Artesia Blvd., Ste. 118, Bellflower, CA 90706 Phone: 562-866-1500 | |
Hanson P Wong M D Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 10230 Artesia Blvd, Suite 201, Bellflower, CA 90706 Phone: 562-804-7223 Fax: 562-804-0165 | |
Kuan Pok Wong M.d. Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10230 Artesia Blvd, #102, Bellflower, CA 90706 Phone: 562-866-1764 Fax: 562-867-7123 | |
Wesley Health Center Bellflower Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14371 Clark Ave, Bellflower, CA 90706 Phone: 562-867-6096 Fax: 213-484-6165 |